Non-invasive prenatal testing (NIPT) is a screening technique used to detect common fetal chromosomal abnormalities from a simple blood draw from the mother. It analyzes fetal DNA from the mother’s blood sample to detect any chromosomal anomalies. NIPT screens for Down syndrome, Edwards syndrome, Patau syndrome, and presence of a sex chromosome abnormalities such as XXY or XYY. It provides over 99% accuracy of detecting trisomies in twin pregnancies and over 99.9% accuracy in singleton pregnancies. The NIPT methodology involves isolating and analyzing tiny fragments of fetal DNA from the mother’s blood sample. As compared to invasive tests such as amniocentesis or chorionic villus sampling which pose risks to the pregnancy, NIPT is completely safe with no risk of miscarriage.
The North Africa Non-Invasive Prenatal Testing Market is estimated to be valued at US$ 3805.83 Bn in 2024 and is expected to exhibit a CAGR of 6.9% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
Rising Adoption of Screening Tests for Genetic Abnormalities – With advancements in medical diagnostics, the adoption of screening tests for detecting genetic abnormalities during pregnancy has increased significantly. NIPT is gaining widespread acceptance among expectant mothers and physicians as the first line screening method due to its high accuracy and non-invasiveness. This rapid uptake is expected to propel the North Africa non-invasive prenatal testing market growth over the forecast period.
Increasing Prevalence of Chromosomal Disorders – According to the National Society for Down Syndrome, Down syndrome occurs in about one in every 700 babies born in the United States each year. Other chromosomal abnormalities such as Edwards syndrome and Patau syndrome also affect about 1 in every 2,500 live births globally. The growing prevalence of these disorders is anticipated to augment the demand for reliable screening methods such as NIPT during the forecast period.
Segment Analysis
The North Africa Non-Invasive Prenatal Testing market size is segmented into prenatal sex screening, microdeletion syndrome analysis, fetal parameter testing, ultrasound screening, and maternal serum testing. The microdeletion syndrome analysis segment dominates the market currently owing to the increasing awareness regarding genetic disorders and availability of advanced tests for it.
PEST Analysis
Political: The regulations regarding prenatal genetic screening and testing vary across different countries in North Africa. However, most governments are working towards increasing awareness and access to such important tests.
Economic: The rising disposable income levels have increased the ability of people to avail advanced healthcare options like NIPT. Further economic growth is also boosting investments in the healthcare sector of these countries.
Social: There is a significant social stigma still associated with genetic disorders in some parts. However, awareness campaigns are changing mindsets and more people are opting for NIPT to rule out any risks.
Technological: Technological advancements have made tests like NIPT more accurate and less invasive. Introduction of advanced diagnostic tools and techniques are helping drive growth in the market.
Key Takeaways
The North Africa Non-Invasive Prenatal Testing market is expected to witness high growth. The North Africa Non-Invasive Prenatal Testing Market is estimated to be valued at US$ 3805.83 Bn in 2024 and is expected to exhibit a CAGR of 6.9% over the forecast period 2024 to 2031.
Regional analysis related content
The North Africa NIPT market is dominated by Egypt and Morocco currently due to rising medical diagnostics spending and infrastructure in these countries. Algeria and Tunisia are also growing markets with increasing acceptability of advanced non-invasive testing options.
Key players related content comprises
Key players operating in the North Africa Non-Invasive Prenatal Testing market are Enraf-Nonius B.V., DJO Global, EMS Physio Ltd., Dynatronics Corporation, A. Algeo Limited, BTL Industries, Inc., HMS Medical Systems, Whitehall Manufacturing, Patterson Companies, Inc., and Isokinetics, Inc. Major players are focusing on strengthening their regional presence through partnerships with local labs and hospitals.